ArticleEndocrine connections2025
Outcomes following hospitalization for diabetic ketoacidosis in patients with cardiovascular disease.
Article in Endocrine connections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Diabetic ketoacidosis (DKA) is a serious complication in patients with diabetes. This study compares the outcomes of hospitalized DKA patients with and without cardiovascular disease (CVD). In addition, we assess outcomes between DKA and hyperosmolar hyperglycemic syndrome (HHS) in diabetes patients with CVD, and between those who developed DKA and those who did not. Methods: We employed a population-based, retrospective observational design utilizing data sourced from the National Inpatient Sample database for the years 2016-2022. The primary outcome assessed was in-hospital mortality. In addition, various secondary outcomes were examined, including the incidence of acute respiratory failure, acute kidney failure, septic shock, sepsis, acute neurological failure, pulmonary embolism, deep vein thrombosis, acute liver failure, mechanical ventilation, noninvasive ventilation, and the length of hospital stay (LOS) and total hospital charges. Results: Multivariable regression analysis demonstrated that CVD independently increased mortality and complications, including acute respiratory failure and sepsis, in DKA patients, who also experienced longer LOS and higher medical costs compared to those without CVD. Similar findings were observed when comparing outcomes between DKA and HHS in diabetes patients with CVD, as well as between those who developed DKA and those who did not. Conclusions: This study demonstrates that CVD significantly affects the outcomes of patients admitted for DKA. Moreover, similar negative outcomes were observed when comparing DKA patients with HHS and those who developed DKA versus those who did not. These findings highlight the need for careful management of DKA in patients with CVD to optimize clinical outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.